Assessment of biological effectiveness of boron neutron capture therapy in primary and metastatic melanoma cell lines

Abstract

These obtained in vitro results are the first effectiveness factors determined for human melanoma at the RA-3 nuclear reactor and show that BNCT dosimetry planning for patients could be successfully performed using these new factors.